Patients with CML in the lymphoid blastic phase have inferior response to anti-CD19 CAR T-cell therapy compared to de novo Ph-positive B cell acute lymphoblastic leukemia

被引：0
|
作者：
Liu, Mei-Jing [1 ,2 ]
Tan, Kai-Wen [1 ,2 ]
Cao, Han-Yu [1 ,2 ]
Huang, Si-Man [1 ,2 ]
Qian, Chong-Sheng [1 ,2 ]
Xue, Sheng-Li [1 ,2 ]
Dai, Hai-Ping [1 ,2 ]
Gong, Wen-Jie [1 ,2 ]
机构：
[1] First Affiliated Hosp Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou 215006, Peoples R China
[2] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
来源：
HEMASPHERE | 2024年 / 8卷 / 02期
关键词：
FOLLOW-UP; DASATINIB; EFFICACY;
D O I：
10.1002/hem3.49
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] A Refractory B-ALL Patient Relapsed with Leukemia Cells Expressing CD19 and Anti-CD19 CAR Gene 14 Days after CR from Anti-CD19 CAR T-Cell Therapy
    Liu Meijing
    Cui, Rui
    Mu, Juan
    Yuan, Ji-Jun
    Mou, Nan
    Yang, Zhen-xing
    Jiang Yan-yu
    Meng Juanxia
    Deng, Qi
    BLOOD, 2019, 134
  • [42] Bone marrow fibrosis is associated with non-response to CD19 CAR T-cell therapy in B-acute lymphoblastic leukemia
    Anil, Joshua
    Alnemri, Ahab
    Lytle, Andrew
    Lockhart, Brian
    Anil, Ashley E.
    Baumgartner, Michael
    Gebre, Kirubel
    Mcferran, Jared
    Grupp, Stephan A.
    Rheingold, Susan R.
    Pillai, Vinodh
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (12) : 1888 - 1897
  • [43] Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL
    Su, Yi-Jiun
    Kramer, Anne Marijn
    Hamilton, Mark P.
    Agarwal, Neha
    Srinagesh, Hrishikesh K.
    Baird, John H.
    Sahaf, Bita
    Kuo, Adam
    Ehlinger, Zachary J.
    Desai, Moksha H.
    Rietberg, Skyler P.
    Tunuguntla, Ramya
    Patel, Shabnum
    Chinnasamy, Harshini
    Gkitsas-Long, Nikolaos
    Klysz, Dorota D.
    Brown, Annie Kathleen
    Bharadwaj, Sushma
    Dahiya, Saurabh
    Smith, Melody
    Muffly, Lori
    Mackall, Crystal L.
    Good, Zinaida
    Feldman, Steven A.
    Miklos, David B.
    Frank, Matthew J.
    CANCER DISCOVERY, 2025, 15 (04) : 733 - 747
  • [44] Pre-Treatment Pulmonary Assessment Have Limited Utility in B-Cell Lymphoma Patients Treated with Autologous Anti-CD19 CAR T-Cell Therapy
    Sdayoor, Inbal
    Shouval, Roni
    Fried, Shalev
    Marcus, Ronit
    Danylesko, Ivetta
    Yerushalmi, Ronit
    Shem-Tov, Noga
    Itzhaki, Orit
    Jacoby, Elad
    Kedmi, Meirav
    Nagler, Arnon
    Shimoni, Avichai
    Segel, Michael J.
    Avigdor, Abraham
    BLOOD, 2023, 142
  • [45] Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis
    Di Blasi, Roberta
    Le Gouill, Steven
    Bachy, Emmanuel
    Cartron, Guillaume
    Beauvais, David
    Le Bras, Fabien
    Gros, Francois-Xavier
    Choquet, Sylvain
    Bories, Pierre
    Feugier, Pierre
    Casasnovas, Olivier
    Bay, Jacques Olivier
    Mohty, Mohamad
    Joris, Magalie
    Gastinne, Thomas
    Sesques, Pierre
    Tudesq, Jean-Jacques
    Vercellino, Laetitia
    Morschhauser, Franck
    Gat, Elodie
    Broussais, Florence
    Houot, Roch
    Thieblemont, Catherine
    BLOOD, 2022, 140 (24) : 2584 - 2593
  • [46] Cellular Immunotherapies: Late Phase and Commercially Available Therapies Impact of Salvage and Bridging Therapy in Adult Patients with Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL) Referred for Anti-CD19 CAR T-Cell Therapy: An Intention to Treat Analysis
    Ortiz-Maldonado, Valentin
    Martinez-Cibrian, Nuria
    Del Campo Balguerias, Gonzalo
    Espanol-Rego, Marta
    Navarro, Sergio
    Brillembourg, Helena
    Alserawan, Leticia
    Castella, Maria
    Benitez-Ribas, Daniel
    Magnano, Laura
    Gonzalo Correa, Juan
    Rivero, Andrea
    Mozas, Pablo
    Oliver-Caldes, Aina
    Gine, Eva
    Gerardo Rodriguez-Lobato, Luis
    Martinez-Roca, Alexandra
    Montoro-Lorite, Mercedes
    Ayora, Pilar
    Fernandez de larrea, Carlos
    Pascal, Mariona
    Esteve Reyner, Jordi
    Urbano-Ispizua, Alvaro
    Juan, Manel
    Delgado, Julio
    BLOOD, 2023, 142
  • [47] Long-Term Follow-Up of Anti-CD19 CAR T-Cell Therapy for B-Cell Lymphoma and Chronic Lymphocytic Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 8 - 9
  • [48] Germline Determinants of Toxicity and Efficacy in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 Autologous CAR T-Cell Therapy
    Strati, Paolo
    Brandt, Amanda
    Henderson, Jared
    Westin, Jason
    Nastoupil, Loretta J.
    Al Zaki, Ajlan
    Jallouk, Andrew P.
    Adkins, Sherry
    Shpall, Elizabeth J.
    Kebriaei, Partow
    Ramdial, Jeremy
    Saini, Neeraj Y.
    Ahmed, Sairah
    Flowers, Christopher R.
    Neelapu, Sattva S.
    Hildebrandt, Michelle
    BLOOD, 2023, 142
  • [49] Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product in a First-in-Human Trial (PALL) in Pediatric Patients with CD19+Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
    Qasim, Waseem
    Ciocarlie, Oana
    Adams, Stuart
    Inglott, Sarah
    Murphy, Claire
    Rivat, Christine
    Wright, Gary
    Lucchini, Giovanna
    Silva, Juliana
    Rao, Kanchan
    Zinai, Amina
    Binlich, Florence
    Dupouy, Sandra
    Pauly, Jeanne
    Balandraud, Svetlana
    Dubois, Frederic
    Konto, Cyril
    Patel, Premal
    Chiesa, Robert
    Samarasinghe, Sujith
    Hara, Havinder
    Boyle, Alayna
    Chu, Jan
    Pinner, Danielle
    Amrolia, Persis J.
    Vora, Ajay
    Rao, Anupama
    Ancliffe, Philip
    Veys, Paul
    BLOOD, 2017, 130
  • [50] Successful 24-Hours Manufacture of Anti-CD19/CD22 Dual Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia (BALL)
    Yang, Junfang
    Jiang, Pengfei
    Zhang, Xian
    Li, Jingjing
    Wu, Yan
    Xu, Li
    Su, Yunchao
    Hu, Xiaona
    Zhao, Xiaoyan
    Dong, Qi
    Cai, Songbai
    Wang, Zhenguang
    Chen, Yuezhang
    Ye, Xun
    He, Jiaping
    Lin, Nanjing
    Cao, Wei
    Sersch, Martina
    Lu, Peihua
    BLOOD, 2020, 136
12345